Background & Summary
====================

Illuminating the link between genes and environment is an exciting yet challenging goal. The full exploration of this link requires model organisms with well-characterized ecological interactions in nature, tractability in the laboratory and available genomic tools. The waterflea *Daphnia magna* Straus satisfies these requirements^[@b1],[@b2]^. *D. magna* occurs in lakes and ponds in Europe, Africa, Asia and America^[@b3],[@b4]^. It has a prominent ecological role in pelagic freshwater food webs, where it is the primary forage for many vertebrate and invertebrate predators^[@b5]^, an efficient grazer of algae^[@b8]^, including cyanobacteria^[@b9]^, a strong competitor for other zooplankters^[@b10]^ and in a constant evolutionary race with parasites^[@b11]^. Experimental tractability is high in *Daphnia* because of the short generation time, comparable to the genetic model species *Drosophila*. The small body size enables experimental approaches on large populations, and the cyclic parthenogenetic life cycle enables the parallel analysis of functional and fitness changes in the same genotype in multiple environmental conditions. Moreover, species of the genus *Daphnia* are renowned models in ecotoxicology and are widely used as indicators of water quality and environmental health^[@b12]^. They are also key models in evolutionary biology and the study of adaptive responses to environmental change^[@b17]^.

Capitalizing on this unique model system, the STRESSFLEA consortium, a research network funded by the ESF EUROCORES Programme EuroEEFG, generated a comprehensive RNA-Seq data set obtained from two natural genotypes, subsequently inbred in the laboratory, and a recombinant line of *D. magna*, obtained from the crossing of the two inbred genotypes, exposed to a suite of biotic and abiotic environmental perturbations. The two inbred genotypes were collected from two ecologically different habitats in the species distributional range. One of the inbred strains has been used to obtain the first draft genome of *D. magna* v2.4 (GenBank LRGB00000000).

Genome-wide transcription profiling was obtained from the three genotypes following environmental perturbations. The EvidentialGene method based on combined RNA-assembly and genome-based modelling of euGenes eukaryote genome informatics (<http://eugenes.org/EvidentialGene/>)^[@b22]^ was used to generate a public gene set for *D. magna* with as complete and accurate gene and transcript repertoire as possible. EvidentialGene uses evidence from public gene expression and protein datasets to annotate new genes. Briefly, for each gene, different models are tested and ranked based on quality scores and on deterministic evidence. Selecting the best representative model for a locus from among a large set of models is accomplished over two criteria: (1) gene evidence must pass a minimum threshold score, and (2) the combined score is maximal for all models overlapping the same coding sequence locations. Other criteria and tests are included and used for classification, such as orthology scores, CDS/UTR quality, and expression and intron evidence. The algorithm used for evidence scoring attempts to match expert choices, using base-level and gene model quality metrics. Determining a final gene set is an iterative process that involves evaluation and expert examination of problematic cases, modification of score weights, and reselection.

The data generated here combined with the *D. magna* draft reference genome and a genetic map available for this species^[@b23]^ will open a new era for environmental genomics. These genome and gene data sets are publicly available in the interactive *Daphnia* genome database at wFleaBase.org^[@b24]^. This database includes a genome map viewer with an option to display expression data (for example from this study) and genome annotation data from *Daphnia pulex* and related species, as well as search functions for queries at sequence, gene function, expression, orthology and annotation levels. The RNA-Seq data generated in this study will enable us to disentangle the relative contribution of genetic adaptation and phenotypic plasticity to adaptation in presence of both natural and anthropogenic stressors. Such investigations are possible because of the rich ecological data available for *Daphnia*, which is arguably the best studied model system in terms of phenotypic and genetic responses to ecological stressors^[@b1],[@b2]^. In combination with the key assets of this model system for experimental work, the transcriptomic data deposited here will enable unprecedented advances in environmental, population and functional genomics.

Methods
=======

Strains
-------

Two inbred genotypes derived from natural strains, and a recombinant line derived from a cross of these two strains, were used to generate the transcriptome of *D. magna*. The two natural strains were collected from a system of ephemeral rock pools from the northern distributional range of the species (Xinb3, South west Finland 59.833183, 23.260387) and a fish-rearing pond in Southern Germany (Iinb1, Germany, 48.206375, 11.709727), respectively. The Xinb3 genotype was the result of three generations of selfing, and the Iinb1 strain was selfed for one generation, leading to a predicted 87.5 and 50% reduction in their original level of heterozygosity, respectively. The recombinant line is an F2 laboratory strain part of a mapping panel supporting research on the genetic basis of adaptive traits in *D. magna*^[@b23],[@b25]^. The strains will hereafter be referred to as X- Xinb3, I- Iinb1, and XI-recombinant line.

Environmental perturbations and experimental design
---------------------------------------------------

Genome-wide transcription profiles were obtained from the three strains following environmental perturbation by a suite of environmental challenges. Exposures to environmental perturbations on the two inbred strains were conducted at the University of Leuven, Belgium. The sequencing for this experiment was performed at the Finnish Institute of Molecular Medicine (FIMM, Technology Centre, Sequencing unit) at the University of Helsinki. Exposures of the recombinant line were completed at the University of Notre Dame, IN, USA. The sequencing data from this experiment were obtained at the JP Sulzberger Columbia Genome Center (<https://systemsbiology.columbia.edu/genome-center>). All exposures to environmental perturbations were conducted using the protocol described below. All three genotypes were maintained in the laboratory for several generations after selfing (X and I) or crossing (XI) to reduce interference from maternal effect prior to the exposures to environmental perturbations.

### Inbred genotypes (X and I)

For the exposure to environmental perturbations, the genotypes were grown in climate chambers with a fixed long day photoperiod (16 h light/8 h dark) at 20 °C. The first generation was cultured at a density of 10 individuals/l, and increased to 50 individuals/l in the second generation to enable the harvesting of enough offspring for the environmental perturbation exposure. Animals were harvested and exposed in ADaM medium (Aachener Daphnien Medium:^[@b26]^). The medium was renewed every second day in the harvesting phase and the daphnids were fed daily with 150,000 cells *Scenedesmus obliquus*/ml. The diet changed to a 2:1*S. obliquus*:*Cryptomonas* sp. mix from the second generation onwards to provide the animals with optimal food quality. When multiple genotypes were used in the same experimental set up, they were synchronized for at least two generations prior to the actual exposures. The second clutch of the second generation was used for exposures to environmental perturbations. Five-day old juveniles at a density of 100 juveniles/l were exposed for 4 h to the different environmental challenges ([Fig. 1](#f1){ref-type="fig"}). Prior to separating the juveniles for the actual exposures, they were grown in groups of 1,000 in 10 l aquaria for four days. The aquaria were fed daily 150,000 cells per ml in a 2:1 *S. obliquus*: *Cryptomonas* sp. Half of the medium was replaced every second day. The animals were not supplied with food during the perturbation exposures to reduce contamination from algae in the sequencing phase. Seven environmental perturbations were imposed on the inbred strains. These consisted of six biotic and one abiotic stressor. The biotic stressors were: kairomone signalling of vertebrate and invertebrate predation, exposure to *Pasteuria ramosa* parasite spores, crowding, and grazing on toxic and non-toxic cyanobacteria; the abiotic stressor was the pesticide Carbaryl (1-napthyl methylcarbamate, Sigma-Aldrich, Germany) ([Fig. 1](#f1){ref-type="fig"}). To mimic fish predation, *Daphnia* were exposed to kairomones-enriched medium obtained from growing 19 sticklebacks in 100 l of water. This medium was obtained from aquaria in which fish was reared. Medium in the fish aquaria was refreshed daily, and kairomone-loaded medium was prepared by filtering the medium over a 0.2 μm filter. This kairomone-loaded medium was added to the *Daphnia* cultures to constitute 10% of the total volume. Similarly, invertebrate predation was mimicked by exposing *Daphnia* to kairomones-enriched medium obtained from growing an adult tadpole shrimp *Triops* in 2 l of water. This medium was obtained by filtering the kairomone-loaded medium on a 0.2 μm filter. Similarly to the fish kairomone experiment, the filtered medium was added to the *Daphnia* cultures to constitute 10% of the total volume. Experimental animals in the parasite treatment were exposed to a solution containing 40,000 spores/ml of *P. ramosa*, a parasite known to have strong fitness consequences in *Daphnia*^[@b11]^. Crowding stress was imposed by increasing the number of experimental animals per volume of medium: 100 individuals in 250 ml of medium as compared to 100 individuals in 1 l. Perturbation from cyanobacteria was obtained by feeding *Daphnia* with a toxic strain of *Microcystis aeruginosa* (Cyanobacteria, strain MT50) and a non-toxic strain of *Microcystis aeruginosa* (strain CCAP 1450/1)^[@b9]^. The experimental animals were exposed to the pesticide Carbaryl in a concentration of 8 μgl^−1^, known to cause appreciable sublethal stress and increased mortality^[@b27]^. The exposures of the inbred strains were completed over two days. For each day a control (no stress) was run in parallel to the environmental perturbations. We performed five biological replicates for each treatment, including controls. Each consisted of ca. 80 sub-adult animals.

### Recombinant genotype (XI)

The recombinant line was maintained as described above for the parental genotypes with the exception that recombinant *Daphnia* were maintained in 1 l containers throughout the rearing phases and for the experimental phase, third generation individuals at eight days old were exposed to five abiotic perturbations linked to anthropogenic disturbance. These exposures included: cadmium (Cd), lead (Pb), low pH (5.5), UV light, and sodium chloride (NaCl) ([Fig. 1](#f1){ref-type="fig"}). The experimental treatments included a single control of individuals placed in fresh media without algae for a 24 h period. All treatments and the control included three biological replicates. The metal exposures were maintained for 24 h at concentrations of 6 μgl^−1^ and 278 μgl^−1^ for Cd and Pb, respectively. *Daphnia* were also exposed to pH 5.5 and media supplemented with 5 g/l NaCl for 24 h. UV light treatments were conducted in 250 ml beakers containing 50 ml of media. Beakers were placed 10.5 cm below 30 W, 36-inch Reptisun 5.0 UVB fluorescent light bulbs for 4 h (Zoo Med Laboratories Inc., San Luis Opispo, CA, USA)^[@b20]^. Exposure to UV light was restricted to 4 h to avoid high mortality observed at 24 h. All recombinant line exposures were conducted at 18 °C and RNA collection was timed to occur at the same time period to minimize circadian variation in expression patterns among treatments.

RNA isolation
-------------

### Inbred genotypes (X and I)

Five biological replicates for each genotype were perturbed with the environmental conditions explained above and RNA-Seq generated from three of the five biological replicates. Having a larger set of exposed biological replicates per genotypes allowed us to choose the three replicates with the highest RNA quality. Total RNA was extracted from pools of ca. 80 juveniles from each genotype and replica by homogenization in the presence of Trizol reagent followed by acidic phenol extraction as described in (ref. [@b28]) and ethanol precipitation. Quality of the isolated RNA was confirmed with Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and only samples showing no RNA degradation were used in subsequent steps. Sequencing was performed on 49 samples: 3 replicates x 2 genotypes x 8 conditions (2 controls were run for genotype X, making the total number of run samples 49, as the environmental exposures were spread over two days).

### Recombinant genotype (XI)

Total RNA was extracted from pools of ca. 50 individuals from each replicate (18 samples: 3 replicates x 6 conditions including control) by homogenization in Trizol reagent and isolating RNA using a Qiagen RNeasy column (Qiagen, Valencia, CA, USA) with on column DNase treatment. RNA quality was assessed as above.

Construction of RNA-seq libraries
---------------------------------

The experimental procedure from library construction to sequencing and downstream analysis was identical for the three genotypes and was as follows.

Library construction was performed on three biological replicates. 1--3 μg of total-RNA was used for isolating poly-A RNA (Dynabeads mRNA purification kit, Ambion, Life Technologies, AS, Oslo, Norway). The poly-A RNA was reverse transcribed to ds-cDNA (SuperScript Double-Stranded cDNA Synthesis Kit, Life Technologies, Carlsbad, CA, USA). Random hexamers (New England BioLabs, Ipswich, MA, USA) were used for priming the first strand synthesis reaction and SPRI beads (Agencourt AMPure XP, Beckman Coulter, Brea, CA, USA) for purification of cDNA. Illumina compatible Nextera Technology (Illumina, Inc., San Diego, CA, USA) was used for preparation of RNA-seq libraries. 60 ng of ds-cDNA was fragmented and tagged using *in vitro* cut-and-paste transposition. The fragmented cDNA was purified with SPRI beads. In order to add the Illumina specific bridge-PCR compatible sites and enrich the library, limited-cycle PCR (5 cycles) was done according to instructions of Nextera system with minor modifications. For bar coded libraries, 50X Nextera Adaptor 2 was replaced with a bar coded Illumina-compatible adaptor from the Nextera Bar Codes kit in PCR setup. SPRI beads were used for purification of the PCR-products and the library QC was evaluated by Agilent Bioanalyzer. Libraries were size selected (350--700 bp) in 2% agarose gel, purified with QIAQuick Gel Extraction kit (Qiagen, Valencia, CA, USA) and the library QC was evaluated by Agilent Bioanalyzer.

RNA-seq library sequencing
--------------------------

C-Bot (TruSeq PE Cluster Kit v3, Illumina, San Diego, CA, USA) was used for cluster generation and Illumina HiSeq2000 platform (TruSeq SBS Kit v3 reagent kit) for paired-end sequencing with 101 bp read length. Sequence data for the inbred genotypes were generated by the FIMM sequencing unit at the University of Helsinki, Finland whereas data from the recombinant genotype were generated by the JP Sulzberger Columbia Genome Center (New York, NY, USA).

RNA-Seq quality check
---------------------

Read sequences were subjected to adapter trimming and quality filtering using Trimmomatic ver.0.33 (ref. [@b29]). RNA-Seq reads were checked for foreign RNA contamination. Human and mouse contaminant sequences were screened and removed by mapping *D. magna* reads onto ncbigno2014-human.rna and ncbigno2014-mouse.rna using bowtie2 ver.2.1.0 (ref. [@b30]). Finally, 80% of the reads for the inbred genotypes and 99% of the reads for the recombinant genotype were retained (Q\>20). Contaminant screening is essential for transcriptome and genome projects; in this study contaminants of 100% RNA identity to mouse, human, and various bacteria genes were found in all source sets, even though not in all replicates. Care should also be taken to avoid false positive contaminant flags, as putative horizontal gene transfer (HGT); one such case was identified in the current dataset. The cleaned reads were mapped onto the reference transcriptome of *D. magna* obtained from *de novo* assembly of RNA-Seq data. These data consisted mostly of the Xinb3 inbred genotype data, but also included a subset of data from the Iinb1 genotype and RNA-Seq available in public databases for *D. magna* at the time of the analysis (mostly^[@b31]^). This reference transcriptome includes only primary transcripts. The mapping of reads from the three genotypes was conducted using Bowtie2 ver.2.1.0 (ref. [@b30]) allowing a maximum edit distance of 3 per read. 74% of the reads mapped on the reference transcriptome and 82% of those mapped to a unique location. The remaining reads mapped to multiple locations suggesting that those are alternative transcripts or incomplete genes that cannot be accurately mapped. These reads will be the object of further investigations.

As an additional assessment of sequence quality, we counted base positions in which more than two allelic variants were present, hence departing from the expectation of a maximum of two alleles at a given position for a diploid organism. For this analysis reads from all treatments for each genotype were pooled and mapped against a reference sequence set of single copy genes from the *D. magna* consensus transcriptome. The mapping process was performed using bowtie2 ver. 2.1.0 30 reporting up to a maximum of 20 valid alignments per read (-k 20); from this pool, alignments with least edit distance were selected as best hits for a specific read. Allelic variants as compared to the reference consensus sequence were identified using samtools mpileup command (samtools ver. 0.1.19, 45), and a custom parser written in perl. The minimum base quality score required for a variation to be considered was q=20 where q is the threshold measured. Variant calls with frequencies below 1% representing typical Illumina sequencing errors^[@b32]^ were excluded. The variant positions with 2, 3 or 4 allelic variants were counted.

Transcriptome and gene set construction
---------------------------------------

### Transcriptome assembly of RNA

We used EvidentialGene methods from the euGenes.org^[@b22]^ project to assemble RNA-seq, as well as annotate and validate transcripts per strain. After assembling transcripts per strain, we constructed a complete gene set across strains incorporating chromosome assembly data available for *D. magna* (draft genome assembly 2.4, GenBank LRGB00000000). Paired end RNA-Seq reads, totalling 7.2 billion reads from the current project and 2 billion reads from published data at the time of the analysis^[@b31]^, were assembled *de-novo* with several RNA assemblers, using multiple options for kmer fragmenting, insert sizes, read coverage, digital normalization, and quality and abundance filtering. *De-novo* RNA assemblers used include Velvet/Oases^[@b33],[@b34]^ \[v1.2.03/o0.2.06\], SOAPDenovo-Trans^[@b35]^ \[v2011.12.22\] using multi-kmer shredding options from 23 to 95 bp, and Trinity^[@b36]^ \[v2012.03.17\] (with fixed kmer option). Accessory methods used for RNA data processing include GMAP/GSNAP and Bowtie for read and transcript mapping to genome assembly, diginorm of khmer package, and sequence artefact filtering. Additional transcripts were assembled with genome-mapping assistance, using PASA^[@b37]^ \[v2.2011\], Cufflinks^[@b38]^ \[v1.0.3 and v0.8\], and EvidentialGene. EvidentialGene *tr2aacds* software pipeline (<http://eugenes.org/EvidentialGene/trassembly.html>) was used to process the resulting assemblies obtained from coding sequences. The assemblies were then translated to proteins, scored for gene evidence including CDS/UTR quality and homology, and reduced to a biologically informative transcriptome of primary and alternate transcripts. We submitted to NCBI only the primary transcripts; alternate transcripts are available at wFleaBase.org.

### Gene set construction

Gene models were also predicted on the draft *D. magna* genome assembly with genome-modelling methods, using AUGUSTUS^[@b39]^, and were incorporated in this public gene set version evg7f9b. Accessory gene set annotation, validation and processing methods included NCBI BLAST suite, exonerate (protein alignment), lastz (sequence alignment), GMAP (gene mapper), CD-Hit (sequence clustering), MUMmer (sequence alignment), MCL (markov clustering), Muscle (sequence alignment), RepeatMasker (repeat and transposon finding), rnaexpress, samtools (rna), SNAP (gene modeller), Splign (alignment), and several database extracts of arthropod and eukaryote genes, proteins and other sequences. A set of primary and alternate transcripts per locus was determined with CDS-overlap discrimination and weighted sum of the several gene evidence scores per transcript model. In hybrid gene set constructions, such as the one presented here, errors occur from both genome map modelling and mRNA assembly, and discrepancies between methods need to be resolved from available gene evidence. The algorithm used for this gene set construction was Evidential Gene and includes three stages:

**Stage 1.** Transcript assemblies of mRNA-seq are performed with several *de-novo* assemblers and parameters, followed by EvidentialGene tr2aacds redundancy removal for each assembly set.**Stage 2.** Locus/alternate gene classification is performed from assembly sets obtained in stage 1 to produce non-redundant gene assemblies for each strain using several attributes: transcript alignment classification (tr2aacds), genome-map location and consensus map loci, consensus protein homology and quality, and cross-strain transcript consensus (MCL clustering of transcript alignments^[@b40]^).**Stage 3.** A candidate locus/alternate gene set for the species is produced from the non-redundant strain sets, using several gene consensus measures across strains, expert curation and computational reclassification. Cases of alternate/paralog discrimination and mis-mapping are investigated in this step using consensus of gene structure among strains, protein orthology analyses, and consensus location on *D. magna* and the sister species *D. pulex* chromosome assemblies.

Stage1 produced separate RNA assemblies for the three genotypes, amounting to 16.5 M transcripts for X, 9.5 M for I, and 3.7 M for XI, plus a 4th genome-assisted de-novo assembly of 1 M transcripts from weak expressed loci (X genotype). Stage 2 produced 1.0 M non-redundant mRNA transcripts ranging from 35,000 to 270,000 transcripts per set across 7 gene sets obtained from strain and genome-based inferences. The gene set obtained in this second stage is derived from 30 million mRNA assemblies obtained in stage 1. Stage 3 involved cross-strain consensus locus determination, including paralog/alternate discrimination, iterative reclassification and refinements, reducing the total set to 29,128 loci and primary transcripts, with 84,882 alternative transcripts found among 17,473 of those loci.

Gene homology evidence for the gene construction pipeline includes 300,000 proteins from 10 species: the waterfleas *Daphnia magna* and *Daphnia pulex* (version 2010, wFleaBase.org), the tiger shrimp *Penaeus monodon* (2013 EvidentialGene), the flour beetle *Tribolium castaneum* (2014 NCBI), the beetle *Pogonus chalceus* (2013 EvidentialGene), the honeybee *Apis mellifera* (2014 NCBI), the wasp *Nasonia vitripennis* (2010 EvidentialGene), the fruitfly *Drosophila melanogaster* (rel5.30 2012), the fish *Maylandia zebra* (NCBI 2014) and humans (UniProt 2011). Orthology and paralogy criteria were assigned using all versus all reciprocal blastp of these species, followed by OrthoMCL^[@b41]^ alignment clustering of genes (Dmag analysis version arp7bor5 in wFleaBase.org). Gene names were assigned to our models on the basis of homology scores to UniProt proteins. The consensus gene family names were obtained from OrthoMCL orthology analyses, in accordance with UniProt protein naming guidelines^[@b42]^.

The basic approach employed by EvidentialGene is similar to other eukaryote genome annotation methods, including NCBI Eukaryote genome annotation pipeline^[@b43]^ (<http://www.ncbi.nlm.nih.gov/genome/annotation_euk/process/>), ENSEMBL genome annotation pipeline (<http://www.ensembl.org/info/genome/genebuild/genome_annotation.html>), TIGR and Broad genome annotation software^[@b44]^, and MAKER^[@b45]^. It differs from these other approaches for its deterministic evidence scoring, detailed per gene annotations, and single-best model/locus approach. A notable divergence from these other methods is the use of hybrid mRNA-assembly and genome modelling which increases the accuracy and completeness of the gene sets generated.

Assessing the gene set completeness
-----------------------------------

Orthology completeness, presence and full length of orthology genes were assessed with OrthoMCL in several steps of the gene set construction and in particular during stage 3 ([Table 1](#t1){ref-type="table"}). For an independent quantitative assessment of orthology completeness we used BUSCO (Benchmarking Universal Single-Copy Orthologs, v1.1, <http://busco.ezlab.org/>^[@b46]^), a recognized benchmark approach for single copy orthologs providing an assessment of orthologs conserved among species. Deviations from completeness are commonly interpreted as technical or, less frequently, biological deviations from the expected gene complement. We compared the gene models of *D. magna* (dmagset7finloc9b.mRNA gene set) with the BUSCO arthropod profiles. In addition, we compared our gene model with the one of four other arthropod species including *Daphnia pulex*, *Apis mellifera, Tribolium castaneum* and *Drosophila melanogaster*. Our analysis includes also multiple genes sets from the same species. Different genes sets are identified with year and source: 1) **Dma_14EV** described here using EvidentialGene methods, 2) **Dma_11G** obtained from genome-modelled *D. magna* genes from 2011 (this gene set will be described in a separate paper presenting the first draft genome of *D. magna*), 3) **Dpu_10EG** and 4) **Dpu_07G** available for *D. pulex*; 5) **Ame_14EV** obtained from *Apis mellifera* RNA-seq publicly available using EvidentialGene methods; 6) **Ame_12G** apis45: OGS v3.2 genome genes; 7) **Tca_14EV** obtained from *Tribolium castaneum* RNA-seq publicly available using EvidentialGene methods; 8) other Ame and Tca publicly available gene sets; 9) **Fly13** and **Fly04** generated in 2013 and 2004 for *Drosophila melanogaster*. An in depth analysis of the different gene sets and discussion of reliability of validation methods will be presented elsewhere.

Data Records
============

*Daphnia magna* transcriptome and related data are published under the International Nucleotide Sequence Database Collaboration BioProject PRJNA284518 (<http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA284518>). The *D. magna* consensus transcriptome for each of the three genotypes studied here and the raw data for each library obtained from different environmental perturbations are deposited in GenBank (Data Citation 1, metadata in [Supplementary Table 2](#S1){ref-type="supplementary-material"}). RNA-seq read and transcript assemblies of RNA-Seq data can be found at this entry. Transcript assemblies generated separately for the two inbred strains are also available at GenBank (Daphnia magna Xinb3, Data Citation 2; Daphnia magna Inb1, Data Citation 3). The X assembly contains 42,990 loci with 253,834 transcripts.

The I assembly contains 36,935 loci with 271,331 transcripts. The X and I annotated assemblies contain coding-sequence validated for primary and alternate transcripts from stage 2 in the EvidentialGene pipeline above ([Table 1](#t1){ref-type="table"}, Dapma6tx and Dapma6ti clone sets), with loci determined by shared exons. Links to public gene set IDs are included with each transcript assembly. The complete hybrid mRNA-assembly and genome-modelled *D. magna* gene set, and draft genome assembly, in standard sequence and GFF annotation data formats, is publicly available at <http://wfleabase.org/genome/Daphnia_magna/openaccess/genes/>. The *D. magna* gene proteins are also available at UniProt <http://www.uniprot.org/uniprot/?query=taxonomy:35525>.

Technical Validation
====================

Metrics of RNA---seq data
-------------------------

A total of 7.2 billion reads were generated, with an average of 107.5 million reads per sample (s.d. 22 million read pairs). The number of reads was 3.5billion (1.75 billion read pairs) for the X, 2.8 billion (1.4 billion read pairs) for I, and 0.8 billion (0.4 billion read pairs) for XI. Of the total number of reads, 77% for X, 81% for I and 77% for XI had quality scores above 30 (analysed with FastQC software^[@b47]^, [Table 2](#t2){ref-type="table"}). In [Table 3](#t3){ref-type="table"} (available online only) we show a detailed analysis of the RNA-Seq data per sample including raw data read pairs before and after trimming quality was applied, as well as insert size. Approximately 70% of the reads retained their full length of 101 bases after trimming ([Table 3](#t3){ref-type="table"}) (available online only). Insert size for each paired-read library was estimated by mapping a random subsample of 1,000,000 reads per sample to the mitochondrial genome sequence on the reference draft genome (reference genome ver.2.4). The size of the insert for each concordantly mapped read pair was estimated and the average drawn over all such read pairs. The insert size for each sample is shown in [Table 3](#t3){ref-type="table"} (available online only).

When using primary transcripts only, the number of reads mapping onto the transcriptome ranged between 61 and 78% ([Fig. 2](#f2){ref-type="fig"}, [Table 4](#t4){ref-type="table"} (available online only)). This percentage reached 98% of all reads when primary and alternate transcripts were used ([Table 5](#t5){ref-type="table"}). If the same read mapped multiple times onto the same transcript, it was counted only once for that transcript. Multiple mapped reads can be alternate transcripts of the same gene or the result of incomplete mapping likely caused by partial sequence of a transcript. The reads mapping to multiple locations will be object of future studies and hence are not discussed further. The read counts per gene ID are shown in [Supplementary Table 1](#S1){ref-type="supplementary-material"}.

The total number of transcripts retained in this study after trimming and quality checks mapped onto 29,128 genes identified with the EvidentialGene model described above. The distribution of read pairs per gene is summarized in [Supplementary Table 1](#S1){ref-type="supplementary-material"}. Between 26,508 and 28,187 transcripts were retrieved across the three genotypes ([Table 6](#t6){ref-type="table"}). The coverage in bp was highest for the X genotype with 5,282.66 and lowest for the XI genotype with 1,952.93 bp ([Table 6](#t6){ref-type="table"}). The difference in transcript-read map rates indicated in [Tables 4](#t4){ref-type="table"} and [5](#t5){ref-type="table"} results from two main factors: (a) alternate transcripts account for 15% of the difference (all versus primary in [Table 5](#t5){ref-type="table"}) and (b) roughly a 10% difference in mapping of primary transcripts can be observed when different methods are adopted. For example GSNAP trims read ends to facilitate alignment to reference similarly to transcript assembly methods that trim and shred reads, whereas other methods like Bowtie do not trim ends.

Allelic variants
----------------

After removing base positions with frequency lower than 1% which can be explained as sequencing errors^[@b32]^, we identified allelic variants with 2 to 4 alleles as compared to the reference set of single copy genes. The large majority of variants had one or two alleles as expected for a diploid organism ([Table 7](#t7){ref-type="table"}), confirming the high quality of our sequences. A small fraction of variants had 3 and 4 alleles. When a cut-off value of 5% on allelic variant calls was applied these variants were further reduced in number. From visual inspection of the alignment we assessed that these variants interested a very small fraction of the transcriptome.

Reproducibility of biological replicates
----------------------------------------

A Principal Component Analysis on trimmed transcripts was used to assess the quality of the RNA-Seq data in terms of reproducibility across the biological replicates. The PCA plot inclusive of all data identified the sample I_BN_r3 as an outlier ([Fig. 3a](#f3){ref-type="fig"}). This sample was removed from downstream analysis as it obscured any signal from both the genotype and the treatment. The PCA plots excluding this outlier showed a clear aggregation of replicates per genotype ([Fig. 3b](#f3){ref-type="fig"}). PCA plots produced separately per natural genotype showed a roughly random distribution of the read counts along the two principal components ([Fig. 3c,d](#f3){ref-type="fig"}) with a tendency of the first replica (r1) to cluster apart from the other two replicates. This may be the effect of slightly earlier developmental stage in r1 as compared to the other two replicas. In the PCA plot of the recombinant line ([Fig. 3e](#f3){ref-type="fig"}), three treatments cluster separately from the others contributing more than 20% to the overall variance along both axes. These are the treatments with exposures of 24 h.

Gene models validation
----------------------

We generated a public gene catalogue for *D. magna* version evg7f9b1, for release to the scientific community. This hybrid gene set produced from both mRNA and genome gene models is available at wFleaBase.org with components available in International Nucleotide Sequence Database (INSDC).

Of the total 29,128 gene loci identified in *D. magna*, 26,825 (92%) genes were assembled from mRNA, and 2,296 (8%) were genome-modelled. 22,059 (76%) of the total recovered genes were complete proteins, and 7,068 (24%) partial proteins. All of these loci are supported by mRNA-Seq and/or protein homology evidence; 65% (18,962) of these genes map completely onto the *D. magna* draft genome assembly 2.4, and 99% (28,127) contains RNA-Seq reads unique to a specific locus. 76% of the total gene loci identified in *D. magna* show homology to other species (blastp e\<=1e-5 to proteins or conserved domains) and 18% (5,170) show homology only to other *Daphnia* species. Finally, 40% of the recovered genes were orthologs to other species using orthology criteria of OrthoMCL, and 16% were paralogs of orthologs. 44% (12,826) of the total set of identified gene loci do not cluster with other species genes. This proportion can be considered unique or evolved in *D. magna*, although many genes derive homology from other species. The high number of *Daphnia* evolved genes is not unexpected considering the large number of eco-responsive genes identified in the related congener *D. pulex*^[@b48]^ and the fact that *Daphnia* species are among the first crustaceans with a draft genome sequence obtained from exposures to ecological stressors. We used the draft genome assembly of *D. magna* v 2.4 as part of the gene construction and validation process. Of this finished gene set, 65% (18,962) map properly onto the assembly with a coverage \>=80%; 35% (10,189) of the genes mapped with low quality scores; 12% (3,389) remained un-mapped, 12% (3,386) partially-mapped, and 12% (3,414) showed split-mapping. These mapped genes include hundreds of trans-spliced and anti-sense loci where mRNA/protein and introns have reversed orientation. Finally, 14% of the genes that could be mapped were single-exon loci. Some of the conflicts among the physical map in the genome assembly v2.4, partially mapped genes and other complexity are artifactual results of draft genome missassemblies. Other of these complexities are located on well assembled portions, including the anti-sense transcription, and appear as true biological complexities. An instance of putative horizontal gene transfer, bacteria to *Daphnia*, was uncovered during contaminant screening. This has been reported in *Daphnia pulex*^[@b49]^ as a kairomone-stress responsive horizontal gene transfer (HGT) gene, and appears to exist in the draft genome of *D. magna*, *D. pulex,* and in *D. galeata* (personal observation DG). An automated contaminant screening flagged this as a contaminant, but further examination of evidence indicates probable *Daphnia* genomic source, with a potential ecological relevance of this gene to *Daphnia* species.

Assessing the transcriptome annotation completeness
---------------------------------------------------

Evidence of high quality and completeness of the *D. magna* genes was provided by both OrthoMCL and the BUSCO analyses ([Table 8](#t8){ref-type="table"} and [Fig. 4](#f4){ref-type="fig"}). According to the OrthoMCL assessment, the current *D. magna* genes are as or more complete than related arthropods gene sets, with few orthologs missing, a higher number of complete genes, and a lower number of fragment outliers detected ([Table 8](#t8){ref-type="table"}). In the BUSCO analysis *D. magna* gene set showed the lowest proportion of missing and fragmented single copy orthologs as compared to the other four arthropod but for two other sets: Ame14evg and Tca14evg ([Fig. 4](#f4){ref-type="fig"}). Notably, the species showing the most complete gene sets in our analysis were the ones in which the EvidentialGene methods was applied. A complete analysis of this method's performance versus other methods is beyond the scope of the present paper and will be discussed elsewhere.

The STRESSFLEA consortium was a collaborative network of 10 Universities, including 7 European and 2 North American Universities. The effort of this consortium allowed us to produce a comprehensive transcriptome data set and a frozen gene catalogue for the premier model system *D. magna*. This effort paves the way to powerful discoveries in environmental and functional genomics elevating *D. magna* to the rank of genomics empowered ecological model species.
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![Workflow of environmental perturbations.\
Two natural genotypes of *D. magna* collected from Finland (Xinb3-X) and Germany (Iinb1-I) and a recombinant line (XI) obtained from the cross of the two natural genotypes were used in experimental perturbations. The three genotypes were synchronized for two generations. The second clutch of the second generation was exposed to environmental perturbations. The environmental perturbations for the natural genotypes were as follows: **FI**: Vertebrate predation mimicked by fish kairomones released by 19 sticklebacks in 100 l water; **TR**: Invertebrate predation mimicked by kairomones released by 1 adult *Triops* in 2 l water; **PA**: exposure to parasite spores by the common parasite *Pasteuria ramosa*---40,000 sporesml^−1^; **CR**: crowding exposure conditions are of 100 individuals/250 ml; **BX** Toxic Cyanobacteria---strain MT50; **BN** Non-toxic Cyanobacteria---strain CCAP 1450/1; **CA**: exposure to the pesticide Carbaryl---8 μgl^−1^; **CO**: control. The environmental perturbations for the recombinant line were as follows: **CD:** Cadmium-6 μgl^−1^; **PB**: Lead-278 μgl^−1^; **pH 5.5**; **UV** light; **NaCl**- 5 gl^−1^; **CO** Control.](sdata201630-f1){#f1}

![Percentage of mapped read pairs.\
Percentage of read pairs per samples mapping to unique (black bars) or to multiple locations (grey bars) in the reference transcriptome of *D. magna.*](sdata201630-f2){#f2}

![PCA plots.\
(**a**) PCA plots including all data, three genotypes (X, I, XI) and their biological replicates; genotypes X and I are in green, whereas genotype XI is in orange. The outlier treatment is the non-toxic cyanobacteria treatment on the I genotype (I_BN_r3 in panel **a**); (**b**) PCA plot including the three genotypes and their biological replicates except for the outlier HS_BN_Ir3; (**c**) PCA plot for the genotype X and its biological replicates; (**d**) PCA plot for the genotype I and its biological replicates; (**e**) PCA plot for the XI genotype and its replicates. Treatments short names are as in [Fig. 1](#f1){ref-type="fig"}; they are depicted with different colours within each panel. The replicates are identified by different symbols.](sdata201630-f3){#f3}

![BUSCO analysis.\
Stacked bar plots showing proportions of gene sets in quality categories for *D. magna* and 4 other arthropod species.. Two gene sets are represented per species, as described in methods, to show effects of construction methods on quality. The categories of genes are: i) complete single copy BUSCO: genes which match a single gene in the BUSCO reference group; ii) fragmented BUSCOs: genes only partially recovered for which the gene length exceeds the alignment length cut-off; iii) missing BUSCO: not recovered genes. Abbreviation for species names are as follows: Dma=*Daphnia magna*; Dpu=*Daphnia pulex*; Ame=*Apis mellifera*; Tca=*Tribolium castaneum*; Fly=*Drosophila melanogaster*. The gene sets sources used for the 4 arthropod species are as follows: 1) **Dma_14EV** dapmagevg14:, Evigene mRNA+genome, 2014.08; 2) **Dma_11G** dapmag11: Evigene genome genes, 2011; 3) **Dpu_10EG** dapplx10evg: Evigene genome genes, 2010; 4) **Dpu_07G** dapplxjgiv11: genome genes, 2007, doi: 10.1126/science.1197761; 5) **Ame_14EV** apisevg14: Evigene mRNA assembly 2014.06; 6) **Ame_12G** apis45: OGS v3.2 genome genes, 2012, doi: 10.1186/1471-2164-15-86; 7) **Tca_14EV** tribcas4evg2: Evigene mRNA assembly, 2014.12; 8) **Tca_12G** tribcas4aug: AUGUSTUS genome genes, tcas4.0, 2014; 9) **Fly_13** drosmel548n: Flybase release 5.48, 2013; 10) **Fly_04** drosmelr4: Flybase release 4.0, 2004.](sdata201630-f4){#f4}

###### *Daphnia magna* gene set generation

  **Input_Tr**   **NR_out**                                                                                          **Name**                                                                                                                                        **Source**
  -------------- ------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------
  Stage 1                                                                                                                                                                                                                                                                  
  3,751,425      140192                                                                                             dmagset36m                                                                                                          Labbe *et al.* 2012May (Dapma6rm, daphmag3, dmag2vel, tag41 id patt)
  16,454,489     256607                                                                                             dmagset56tx                                                                                                            X assembly, 2014Jun-2013Aug (Dapma6tx, hsX, ndX, vel4x id patt)
  9,469,773      272398                                                                                             dmagset56ri                                                                                                                   I assembly, 2014May (Dapma6ti,hsI,vel4i id patt)
  1,000,000      64487                                                                                              dmagset56ru                                                                                        Assembly from X weakly expressed genes, 1st pass unassembled reads 2014Jun (Dapma6rx, xun, nun id patt)
  Stage 2                                                                                                                                                                                                                                                                  
  34530                                                                                                             dmagset1m8                                                                                                                          Genome predicted 2011 (m8AUG id patt)
  140192                                                                                                            dmagset36m                                                                                                        Labbe *et al.* rna 2012 May (Dapma6rm, daphmag3, dmag2vel, tag41 id patt)
  256607                                                                                                            dmagset56tx                                                                                                            X assembly, 2014Jun-2013Aug (Dapma6tx, hsX, ndX, vel4x id patt)
  272398                                                                                                            dmagset56ri                                                                                                         I assembly, 2014 May (Dapma6ti,hsI,vel4i ids) of 9469773 input trasm
  64487                                                                                                             dmagset56ru                                                                                         Assembly from X weakly expressed genes, 1st pass unassembled reads 2014 Jun (Dapma6rx, xun, nun ids)
  120122                                                                                                          dmagset4pub1208                                                                                                      Present study rna data 2012 Aug, X mostly, used to fill in missed loci
  182909                                                                                                         dmagset5xpub1401                                                                                                   Pre-release 2014Jan, used to fill in missed loci, from 2013--2010 transcripts
  Stage 3                                                                                                                                                                                                                                                                  
  **Name**       **nLoci**                                                                                           **Notes**                                                                                                                                             
  pubset1        97140         evg7vose-tr2aacds, input of 4 separately assembled and reduced RNA-seq sets (3-clones) and genome-predict set, no-omcl 04Jul2014. Sets 4 (1208) and 5 (1401) were not pubset1 inputs.                                                       
  pubset2        44762                                                   no-omcl 24Jul2014; cross-clone consensus classification (MCG loci/alts common across clone sets)                                                                                                  
  pubset3        28363                                                                                   arp7aor1 orthology set, 30Jul2014                                                                                                                                 
  pubset4        27239                                                                       no-omcl 14Aug2014; intron-miss loci, paralog/alt reclass                                                                                                                      
  pubset5        27218                                                          no-omcl 19Aug2014; remove \~1,200 contaminant assemblies (human,mouse,bacteria,..)                                                                                                         
  pubset6        26886                                                                     no-omcl 20Aug2014; intron-miss loci, paralog/alt reclass, v2                                                                                                                    
  pubset7        27775                                                                              arp7bor2b orthology completion, 21Aug2014,                                                                                                                             
  pubset8        28400                                                            arp7bor3b orthology, 21Sep2014, various checks, \~600 missed loci from analyses                                                                                                          
  pubset9a       29074                                                                                    arp7bor4 orthology, 24Sep2014,                                                                                                                                   
  pubset9b       29127                                                                         arp7bor5 orthology, 30Sep2014, found 55 ortho-misses                                                                                                                        

###### RNA---Seq metrics overview.

                                                     **X**           **I**          **XI**
  --------------------------------------------- --------------- --------------- ---------------
  Number of read pairs                           3,403,673,296   2,812,630,218    443,120,153
  Median read pairs per sample                    66,965,781      57,197,308     22,617,799.5
  Mean read pairs per sample                     68,073,465.92   58,596,462.88   24,617,786.28
  Number of reads pairs with phred score \>30    2,621,703,528   2,273,042,316    341,213,774
  Mean phred score per sequence                      32.67           33.29           33.73
  Median phred score per sequence                    35.00           36.00           35.86
  Number of environmental exposures                    8               8               6
  Number of libraries                                 25              24              18

###### Summary of RNA-Seq raw data metrics

  **Sample ID**    **Genotype**   **Sample Code**   **Treatment Code**   **Replicate**  **Raw Read Pairs**   **Trimmed Read Pairs**   **Percentage**   **Insert_Size**   **StdDev**
  --------------- -------------- ----------------- -------------------- --------------- -------------------- ------------------------ ---------------- ----------------- ------------
  I_CO_r1_03            I             Dman_03               CO                r1        63,494,959.000       49,603,877.000           78.12%           289               137
  I_CA_r1_05            I             Dman_05               CA                r1        62,993,811.000       49,028,587.000           77.83%           311               188
  I_BX_r1_09            I             Dman_09               BX                r1        60,794,872.000       48,712,777.000           80.13%           292               156
  I_TR_r1_13            I             Dman_13               TR                r1        55,021,109.000       43,773,368.000           79.56%           319               173
  I_FI_r1_15            I             Dman_15               FI                r1        58,768,662.000       48,858,401.000           83.14%           276               143
  I_BN_r1_21            I             Dman_21               BN                r1        68,881,858.000       55,980,417.000           81.27%           272               116
  I_PA_r1_23            I             Dman_23               PA                r1        73,454,356.000       60,869,142.000           82.87%           298               141
  I_CR_r1_27            I             Dman_27               CR                r1        64,360,226.000       53,858,355.000           83.68%           287               90
  I_CO_r2_29            I             Dman_29               CO                r2        53,507,535.000       44,845,409.000           83.81%           268               144
  I_CO_r3_31            I             Dman_31               CO                r3        50,103,302.000       44,154,666.000           88.13%           277               151
  I_CA_r2_35            I             Dman_35               CA                r2        54,459,613.000       47,952,269.000           88.05%           262               92
  I_BX_r2_36            I             Dman_36               BX                r2        58,852,394.000       51,366,050.000           87.28%           289               139
  I_BX_r3_38            I             Dman_38               BX                r3        48,433,025.000       38,663,288.000           79.83%           265               87
  I_FI_r2_39            I             Dman_39               FI                r2        51,705,574.000       41,476,171.000           80.22%           269               153
  I_FI_r3_41            I             Dman_41               FI                r3        48,109,963.000       38,197,802.000           79.40%           271               146
  I_CA_r3_44            I             Dman_44               CA                r3        56,372,343.000       45,134,149.000           80.06%           255               89
  I_BN_r2_46            I             Dman_46               BN                r2        54,184,465.000       44,125,200.000           81.44%           298               130
  I_BN_r3_47            I             Dman_47               BN                r3        47,781,030.000       39,153,548.000           81.94%           304               195
  I_CR_r2_50            I             Dman_50               CR                r2        48,214,069.000       40,159,238.000           83.29%           279               120
  I_CR_r3_52            I             Dman_52               CR                r3        51,730,328.000       42,678,747.000           82.50%           283               121
  I_TR_r2_53            I             Dman_53               TR                r2        58,022,273.000       46,414,803.000           79.99%           283               150
  I_TR_r3_54            I             Dman_54               TR                r3        82,196,854.000       70,756,025.000           86.08%           295               120
  I_PA_r2_56            I             Dman_56               PA                r2        72,623,134.000       62,031,907.000           85.42%           288               122
  I_PA_r3_58            I             Dman_58               PA                r3        62,249,354.000       51,270,680.000           82.36%           292               88
  X_CO_r1_32            X             Dman_32               CO                r1        71,868,056.000       54,279,251.000           75.53%           278               111
  X_CA_r1_33            X             Dman_33               CA                r1        52,241,312.000       39,732,399.000           76.06%           286               152
  X_FI_r1_42            X             Dman_42               FI                r1        71,287,854.000       57,746,708.000           81.00%           283               172
  X_BN_r1_45            X             Dman_45               BN                r1        61,527,322.000       49,445,396.000           80.36%           280               132
  X_BX_r1_48            X             Dman_48               BX                r1        66,965,781.000       50,685,192.000           75.69%           266               114
  X_CR_r1_51            X             Dman_51               CR                r1        76,818,434.000       59,552,351.000           77.52%           246               87
  X_PA_r1_55            X             Dman_55               PA                r1        58,307,384.000       44,248,248.000           75.89%           251               85
  X_CA_r2_60            X             Dman_60               CA                r2        65,880,062.000       50,044,254.000           75.96%           237               81
  X_CA_r3_61            X             Dman_61               CA                r3        66,867,949.000       50,405,221.000           75.38%           232               83
  X_CO_r2_62            X             Dman_62               CO                r2        67,659,124.000       51,393,424.000           75.96%           241               125
  X_FI_r2_64            X             Dman_64               FI                r2        70,280,087.000       54,395,752.000           77.40%           243               85
  X_FI_r3_65            X             Dman_65               FI                r3        66,226,108.000       50,516,556.000           76.28%           255               116
  X_BX_r2_67            X             Dman_67               BX                r2        67,379,171.000       51,252,578.000           76.07%           286               145
  X_BX_r3_68            X             Dman_68               BX                r3        81,455,682.000       67,969,702.000           83.44%           291               111
  X_TR_r1_70            X             Dman_70               TR                r1        57,871,883.000       48,655,208.000           84.07%           279               163
  X_TR_r2_73            X             Dman_73               TR                r2        58,433,654.000       49,868,737.000           85.34%           281               144
  X_BN_r2_74            X             Dman_74               BN                r2        75,608,849.000       57,220,416.000           75.68%           287               134
  X_PA_r2_75            X             Dman_75               PA                r2        63,636,165.000       51,803,268.000           81.41%           261               104
  X_CO_r3_76            X             Dman_76               CO                r3        90,321,814.000       73,595,073.000           81.48%           271               101
  X_CO_r4_77            X             Dman_77               CO                r4        118,207,131.000      87,998,612.000           74.44%           278               154
  X_CR_r2_78            X             Dman_78               CR                r2        62,101,323.000       54,966,131.000           88.51%           287               139
  X_CR_r3_79            X             Dman_79               CR                r3        90,997,555.000       78,494,531.000           86.26%           254               160
  X_PA_r3_80            X             Dman_80               PA                r3        58,790,865.000       50,985,812.000           86.72%           43                112
  X_BN_r3_83            X             Dman_83               BN                r3        83,174,861.000       71,186,306.000           85.59%           228               141
  X_TR_r3_84            X             Dman_84               TR                r3        46,523,201.000       33,845,684.000           72.75%           226               117
  XI_CD_r1_01           XI             XI_01                CD                r1        35,429,813.000       35,359,972.000           99.80%           166               53
  XI_CD_r2_02           XI             XI_02                CD                r2        58,550,652.000       58,459,895.000           99.84%           166               54
  XI_CD_r3_03           XI             XI_03                CD                r3        16,981,329.000       16,957,777.000           99.86%           164               53
  XI_CO_r1_04           XI             XI_04                CO                r1        17,549,155.000       17,526,674.000           99.87%           173               98
  XI_CO_r2_05           XI             XI_05                CO                r2        12,968,443.000       12,951,973.000           99.87%           161               52
  XI_CO_r3_06           XI             XI_06                CO                r3        22,191,696.000       22,165,545.000           99.88%           166               150
  XI_PB_r1_07           XI             XI_07                PB                r1        13,209,418.000       13,022,646.000           98.59%           160               49
  XI_PB_r2_08           XI             XI_08                PB                r2        25,098,583.000       25,063,912.000           99.86%           168               121
  XI_PB_r3_09           XI             XI_09                PB                r3        20,147,612.000       20,119,479.000           99.86%           164               53
  XI_PH5_r1_10          XI             XI_10               PH5                r1        17,117,432.000       16,780,537.000           98.03%           160               48
  XI_PH5_r2_11          XI             XI_11               PH5                r2        23,043,903.000       22,676,257.000           98.40%           158               49
  XI_PH5_r3_12          XI             XI_12               PH5                r3        28,299,589.000       27,784,289.000           98.18%           163               51
  XI_NaCl_r1_13         XI             XI_13               NaCl               r1        9,454,837.000        9,279,727.000            98.15%           167               50
  XI_NaCl_r2_14         XI             XI_14               NaCl               r2        14,129,350.000       13,855,321.000           98.06%           165               49
  XI_NaCl_r3_15         XI             XI_15               NaCl               r3        36,387,177.000       35,659,077.000           98.00%           164               50
  XI_UV_r1_16           XI             XI_16                UV                r1        35,314,952.000       34,645,324.000           98.10%           166               49
  XI_UV_r2_17           XI             XI_17                UV                r2        33,396,591.000       32,775,509.000           98.14%           167               49
  XI_UV_r3_18           XI             XI_18                UV                r3        23,849,621.000       23,398,424.000           98.11%           166               49

###### Mapping metrics

  **Sample ID**   **Input**     **Mapped**    **Percentage**   **Unique**    **PercentU**   **Multiple**   **PercentM**
  --------------- ------------- ------------- ---------------- ------------- -------------- -------------- --------------
  I_BN_r1_21      111,960,834   80,083,757    71.53%           66,413,218    82.93%         13,670,539     17.07%
  I_BN_r2_46      88,250,400    65,226,041    73.91%           52,033,898    79.77%         13,192,143     20.23%
  I_BN_r3_47      78,307,096    59,500,967    75.98%           48,036,297    80.73%         11,464,670     19.27%
  I_BX_r1_09      97,425,554    74,283,576    76.25%           62,543,895    84.20%         11,739,681     15.80%
  I_BX_r2_36      102,732,100   77,145,075    75.09%           61,447,456    79.65%         15,697,619     20.35%
  I_BX_r3_38      77,326,576    58,031,769    75.05%           46,638,628    80.37%         11,393,141     19.63%
  I_CA_r1_05      98,057,174    75,699,788    77.20%           64,032,567    84.59%         11,667,221     15.41%
  I_CA_r2_35      95,904,538    71,544,033    74.60%           57,839,196    80.84%         13,704,837     19.16%
  I_CA_r3_44      90,268,298    64,558,279    71.52%           52,145,719    80.77%         12,412,560     19.23%
  I_CO_r1_03      99,207,754    74,962,960    75.56%           63,416,691    84.60%         11,546,269     15.40%
  I_CO_r2_29      89,690,818    65,887,322    73.46%           53,024,248    80.48%         12,863,074     19.52%
  I_CO_r3_31      88,309,332    66,542,581    75.35%           54,249,318    81.53%         12,293,263     18.47%
  I_CR_r1_27      107,716,710   65,832,256    61.12%           55,207,910    83.86%         10,624,346     16.14%
  I_CR_r2_50      80,318,476    60,003,726    74.71%           48,426,482    80.71%         11,577,244     19.29%
  I_CR_r3_52      85,357,494    63,331,741    74.20%           51,823,192    81.83%         11,508,549     18.17%
  I_FI_r1_15      97,716,802    69,325,492    70.95%           57,272,131    82.61%         12,053,361     17.39%
  I_FI_r2_39      82,952,342    60,811,958    73.31%           49,298,557    81.07%         11,513,401     18.93%
  I_FI_r3_41      76,395,604    57,925,361    75.82%           46,653,689    80.54%         11,271,672     19.46%
  I_PA_r1_23      121,738,284   85,390,378    70.14%           71,455,076    83.68%         13,935,302     16.32%
  I_PA_r2_56      124,063,814   92,077,396    74.22%           75,330,778    81.81%         16,746,618     18.19%
  I_PA_r3_58      102,541,360   76,400,295    74.51%           61,663,768    80.71%         14,736,527     19.29%
  I_TR_r1_13      87,546,736    64,947,049    74.19%           55,400,302    85.30%         9,546,747      14.70%
  I_TR_r2_53      92,829,606    66,809,655    71.97%           54,544,356    81.64%         12,265,299     18.36%
  I_TR_r3_54      141,512,050   104,106,636   73.57%           84,382,620    81.05%         19,724,016     18.95%
  X_BN_r1_45      98,890,792    71,840,880    72.65%           59,566,099    82.91%         12,274,781     17.09%
  X_BN_r2_74      114,440,832   85,650,437    74.84%           71,414,344    83.38%         14,236,093     16.62%
  X_BN_r3_83      142,372,612   108,233,621   76.02%           86,494,740    79.91%         21,738,881     20.09%
  X_BX_r1_48      101,370,384   71,969,721    71.00%           59,654,388    82.89%         12,315,333     17.11%
  X_BX_r2_67      102,505,156   77,480,991    75.59%           64,605,122    83.38%         12,875,869     16.62%
  X_BX_r3_68      135,939,404   100,320,333   73.80%           83,979,132    83.71%         16,341,201     16.29%
  X_CA_r1_33      79,464,798    55,469,313    69.80%           46,582,761    83.98%         8,886,552      16.02%
  X_CA_r2_60      100,088,508   75,112,653    75.05%           60,181,010    80.12%         14,931,643     19.88%
  X_CA_r3_61      100,810,442   74,154,574    73.56%           60,414,064    81.47%         13,740,510     18.53%
  X_CO_r1_32      108,558,502   81,543,420    75.11%           67,655,636    82.97%         13,887,784     17.03%
  X_CO_r2_62      102,786,848   75,848,649    73.79%           62,061,875    81.82%         13,786,774     18.18%
  X_CO_r3_76      147,190,146   106,434,191   72.31%           88,808,043    83.44%         17,626,148     16.56%
  X_CO_r4_77      175,997,224   122,205,443   69.44%           101,558,190   83.10%         20,647,253     16.90%
  X_CR_r1_51      119,104,702   81,268,612    68.23%           67,293,396    82.80%         13,975,216     17.20%
  X_CR_r2_78      109,932,262   79,815,181    72.60%           66,586,543    83.43%         13,228,638     16.57%
  X_CR_r3_79      156,989,062   99,288,707    63.25%           82,718,053    83.31%         16,570,654     16.69%
  X_FI_r1_42      115,493,416   84,630,965    73.28%           70,317,972    83.09%         14,312,993     16.91%
  X_FI_r2_64      108,791,504   79,180,393    72.78%           65,196,666    82.34%         13,983,727     17.66%
  X_FI_r3_65      101,033,112   74,878,527    74.11%           60,869,160    81.29%         14,009,367     18.71%
  X_PA_r1_55      88,496,496    65,061,089    73.52%           52,747,415    81.07%         12,313,674     18.93%
  X_PA_r2_75      103,606,536   75,988,380    73.34%           62,713,686    82.53%         13,274,694     17.47%
  X_PA_r3_80      101,971,624   76,658,837    75.18%           62,960,881    82.13%         13,697,956     17.87%
  X_TR_r1_70      97,310,416    72,713,118    74.72%           60,631,515    83.38%         12,081,603     16.62%
  X_TR_r2_73      99,737,474    70,684,693    70.87%           59,520,497    84.21%         11,164,196     15.79%
  X_TR_r3_84      67,691,368    49,660,414    73.36%           40,536,759    81.63%         9,123,655      18.37%
  XI_CD_r1_01     70,719,944    54,379,411    76.89%           42,974,691    79.03%         11,404,720     20.97%
  XI_CD_r2_02     116,919,790   90,081,361    77.05%           71,488,938    79.36%         18,592,423     20.64%
  XI_CD_r3_03     33,915,554    25,034,185    73.81%           19,821,595    79.18%         5,212,590      20.82%
  XI_CO_r1_04     35,053,348    26,605,116    75.90%           21,802,150    81.95%         4,802,966      18.05%
  XI_CO_r2_05     25,903,946    19,443,392    75.06%           15,771,894    81.12%         3,671,498      18.88%
  XI_CO_r3_06     44,331,090    34,471,382    77.76%           28,113,780    81.56%         6,357,602      18.44%
  XI_NaCl_r1_13   18,559,454    13,363,593    72.00%           11,155,291    83.48%         2,208,302      16.52%
  XI_NaCl_r2_14   27,710,642    20,737,809    74.84%           17,426,679    84.03%         3,311,130      15.97%
  XI_NaCl_r3_15   71,318,154    52,907,126    74.18%           44,197,531    83.54%         8,709,595      16.46%
  XI_PH5_r1_10    33,561,074    25,250,026    75.24%           20,629,525    81.70%         4,620,501      18.30%
  XI_PH5_r2_11    45,352,514    33,802,651    74.53%           27,780,026    82.18%         6,022,625      17.82%
  XI_PH5_r3_12    55,568,578    41,739,579    75.11%           34,148,330    81.81%         7,591,249      18.19%
  XI_PB_r1_07     26,045,292    19,574,223    75.15%           15,859,586    81.02%         3,714,637      18.98%
  XI_PB_r2_08     50,127,824    38,936,820    77.68%           31,320,244    80.44%         7,616,576      19.56%
  XI_PB_r3_09     40,238,958    30,335,619    75.39%           24,569,127    80.99%         5,766,492      19.01%
  XI_UV_r1_16     69,290,648    51,584,530    74.45%           43,040,794    83.44%         8,543,736      16.56%
  XI_UV_r2_17     65,551,018    48,492,486    73.98%           40,789,403    84.11%         7,703,083      15.89%
  XI_UV_r3_18     46,796,848    35,412,890    75.67%           30,005,050    84.73%         5,407,840      15.27%

###### RNA-Seq read mapping statistics.

  **Strain**    **mRNA set**  **TotR**     **MapR**     **%Map**
  ------------ -------------- ------------ ------------ ----------
  X                 all       3233374500   3172301416   98.1%
  I                 all       2789627581   2736214261   98.1%
  XI                all       885996197    857334019    96.8%
  X               primary     3233374500   2814739850   87.1%
  I               primary     2789627581   2429376789   87.1%
  XI              primary     885996197    791867853    89.4%

###### Transcripts statistics.

  **Strain**                     **X**             **I**            **XI**
  ------------------------ ----------------- ----------------- ----------------
  Number of Transcripts         27,441            28,187            26,508
  Length of Transcripts       48,072,095        48,822,339        47,088,659
  Number of Bases Mapped    253,948,429,576   217,093,998,202   91,961,017,164
  Coverage (bp)                5,282.66          4,446.61          1,952.93

###### Allelic variants.

  **Alleles**    **X**    **I**    **XI**
  ------------- -------- -------- --------
  **≤2**         17,252   23,329   23,436
  **3**           607      580      614
  **4**            45       25       24

###### Gene set completeness.

  **Species**                  **aaSize**   **Frag%**   **OrMiss**  **OrGroup**
  --------------------------- ------------ ----------- ------------ -------------
  *Daphnia magna*                  46         1.8%          18      11523
  *Daphnia pulex*                 −25         5.1%          36      11670
  *Tribolium castaneum*           −26         4.1%          42      8765
  *Apis mellifera*                 38         3.1%         161      8682
  *Drosophila melanogaster*        68         1.8%         203      7801
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